Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Semin Cardiothorac Vasc Anesth ; 13(1): 44-55, 2009 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-19147529

RESUMO

Although cardiac output (CO) monitoring is usually only used in intensive care units (ICUs) and operating rooms, there is increasing evidence that CO should be determined and optimized as early as possible, even before admission to the ICU, in the care of hemodynamically compromised patients. A variety of different minimally or noninvasive CO determination techniques have been developed, but not all of them are suitable for early hemodynamic monitoring outside the ICU. In this review, the different available methods for CO monitoring are presented and their potential for early hemodynamic assessment is discussed.


Assuntos
Débito Cardíaco/fisiologia , Hemodinâmica/fisiologia , Monitorização Intraoperatória/métodos , Animais , Dióxido de Carbono , Cardiografia de Impedância , Corantes , Cuidados Críticos , Ecocardiografia Transesofagiana , Humanos , Técnicas de Diluição do Indicador , Verde de Indocianina , Lítio , Termodiluição , Ultrassonografia Doppler
2.
Pflege ; 21(1): 37-48, 2008 Feb.
Artigo em Alemão | MEDLINE | ID: mdl-18478685

RESUMO

Critically ill patients are at a particular risk for developing pressure ulcers. Yet until now, no sufficiently specific, validated pressure ulcer risk assessment instruments exist for critically ill patients. In a prospective study of 698 patients of medical intensive care unit (ICU), we therefore analyzed if the Waterlow scale is suitable for pressure ulcer risk assessment in the ICU. Only patients with no pressure ulcer on admission to the ICU were included. The Waterlow scale was used to assess pressure ulcer risk on admission to the ICU, and the number of points on the scale were analyzed with regard to pressure ulcers development in the course of the ICU stay (121 patients). Our results show that adequate pressure ulcer risk assessment on admission to the ICU is not possible with the Waterlow scale. Sensitivity and specificity reached their maximal values of 64.6% and 48.8%, respectively, at a comparably high cut-off of 30 points on the Waterlow scale (positive and negative likelihood ratio being 1.26 and 0.73, respectively). The area under the curve (AUC) was 0.59 in the receiver-operator-characteristic curve. Adding intensive care related parameters to the scale yielded some degree of improvement (AUC 0.69), but the development of ICU specific pressure ulcer risk scales still seems to be necessary to allow reliable pressure ulcer risk assessment in the ICU.


Assuntos
Unidades de Terapia Intensiva , Avaliação em Enfermagem/estatística & dados numéricos , Úlcera por Pressão/enfermagem , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Feminino , Humanos , Funções Verossimilhança , Masculino , Pessoa de Meia-Idade , Úlcera por Pressão/etiologia , Úlcera por Pressão/prevenção & controle , Estudos Prospectivos , Curva ROC , Medição de Risco
3.
Transplantation ; 76(2): 430-2, 2003 Jul 27.
Artigo em Inglês | MEDLINE | ID: mdl-12883206

RESUMO

BACKGROUND: Cytomegalovirus (CMV) reactivation occurs frequently in the first months after renal transplantation. However, reports concerning long-term kidney transplant recipients are rare and have always pertained to symptomatic CMV disease. METHODS: We report four cases of late-onset asymptomatic CMV reactivation in critically ill renal transplant patients who suffered from severe bacterial infections and in whom CMV antigenemia was observed. RESULTS AND CONCLUSION: CMV reactivation in these patients might indicate an additional disturbance in the patients' immune defenses at the time of critical illness, possibly even necessitating a temporary reduction in immunosuppressive therapy. Prospective, controlled trials are needed to define the role of CMV antigenemia in critically ill patients, including the role of antiviral therapy for asymptomatic reactivations.


Assuntos
Infecções Bacterianas/complicações , Infecções por Citomegalovirus/complicações , Transplante de Rim , Doença Aguda , Idoso , Antivirais/administração & dosagem , Estado Terminal , Infecções por Citomegalovirus/tratamento farmacológico , Feminino , Ganciclovir/administração & dosagem , Humanos , Pessoa de Meia-Idade , Neutrófilos/virologia , Fosfoproteínas/análise , Recidiva , Superinfecção/complicações , Fatores de Tempo , Proteínas da Matriz Viral/análise
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...